CASPAR (Alliance A031902) - A Randomized, Phase III Trial of Enzalutamide with/without Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      Google Scholar   
Citation:
J Clin Oncol vol 39 (6_suppl) TPS181
Meeting Instance:
ASCO GU 2021
Year:
2021
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                       
Networks:
KANSAS, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NH012, LAPS-NY016, MN022, MUSC, TX041   
Study
Alliance-A031902
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: